Influence of Close Resection Margins on Local Recurrence and Disease-specific Survival in Oral and Oropharyngeal Carcinoma
Overview
General Surgery
Authors
Affiliations
There is a lack of consistency among published reports in the definition of what constitutes close resection margins (1-5mm) in the surgical treatment of oral and oropharyngeal squamous cell carcinoma (SCC). Our aim was to define what would constitute close resection margins in predicting local recurrence and disease-specific survival. The study comprised 192 previously untreated patients with oral and oropharyngeal SCC who were recruited at the Southern General Hospital, Glasgow, from 2001 to 2007 with a minimum follow-up of 2 years. Resection was the primary treatment and the surgical margins were recorded for all patients. Statistical analyses were aided by the Statistical Package for the Social Sciences, version 15.0, and MedCalc software. The status of the surgical margins was evaluated using a receiver operating characteristic (ROC) curve to define the cut-off point. Cox's proportional hazard model was used to establish predictive factors for local recurrence and disease-specific survival. Of 192 patients, 23 (12%) had involved margins (<1.0mm), 107 (56%) had close margins (1.0-2.0mm (16.1%); 2.1-3.0mm (12%); 3.1-4.0mm (10.4%); 4.1-5.0mm (17.2%), and 62 (32.3%) had clear margins (>5mm). No predictive cut-off point was found that related close surgical margins to local recurrence. However, there was a significant adverse association between surgical margins ≤1.6mm and disease-specific survival. In recommending postoperative adjuvant treatment for oral and oropharyngeal SCC, we suggest that surgical margins within 2mm should be considered as the cut-off. However, other clinical and pathological prognostic factors should also be taken into consideration when recommending further treatment.
Pleomorphic adenoma parotid surgery, how much margin we can reach to be safe?.
Mohebbi S, Zahedi M, Basir Shabestari S, Ahmadi A, Kazemipour S, Kadkhoda-Mohammadi M Dent Res J (Isfahan). 2025; 22:6.
PMID: 40028505 PMC: 11870331. DOI: 10.4103/drj.drj_336_24.
Li K, Yang J, Lian H, Tian Z, Li C, Gao N Quant Imaging Med Surg. 2024; 14(12):8167-8182.
PMID: 39698655 PMC: 11651944. DOI: 10.21037/qims-24-564.
Rethinking Surgical Margins: A New Approach to Predict Outcomes in Oral Squamous Cell Carcinoma.
Dudkiewicz D, Yosefof E, Shpitzer T, Mizrachi A, Yehuda M, Shoffel-Havakuk H Laryngoscope. 2024; 135(1):161-167.
PMID: 39230351 PMC: 11635150. DOI: 10.1002/lary.31744.
Lang K, Held T, Freudlsperger C, Plath K, Hoffmann J, Plinkert P Technol Cancer Res Treat. 2024; 23:15330338241258596.
PMID: 39043205 PMC: 11271090. DOI: 10.1177/15330338241258596.
Surgical margins in head and neck squamous cell carcinoma: A narrative review.
Chen Y, Zhong N, Cao L, Liu B, Bu L Int J Surg. 2024; 110(6):3680-3700.
PMID: 38935830 PMC: 11175762. DOI: 10.1097/JS9.0000000000001306.